AGP Limited Secures 1st Position at BCSR Awards 2023

AGP collaborates with Childlife Foundation on Children’s Day 2023

AGP Launched Peridots – A Thanda Solution to Acidity, Gas and Indigestion

AGP secures 2nd Position at BCR Awards 2022

AGP wins Top Exporter Award at 6th PPMA Summit

AGP sponsors KDSP Carnival 2023

AGP bags big win at GDEIB Awards 2023

AGP continues partnership with IBA

AGP continues collaboration with TCF

AGP joins hands with SKMF

AGP continues partnership with ACF

AGP conducts Allergy Awareness Session At Pak Turk Maarif

Gong-Ringing Ceremony of AGP at PSX

Home > Products > TruGlif

Product List

TruGlif

Generic:

Empagliflozin
 

Therapeutic Class:

SGLT2 Inhibitors Antidiabetic Plain

 

Composition:

Each TruGlif tablet contains 10 mg or 25 mg of Empagliflozin
 

Description:

TruGlif tablets contain empagliflozin, an orally active inhibitor of the Sodium-Glucose Co-Transporter 2 (SGLT2).

 

Indications:

TruGlif is indicated:

 

• As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

• To reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease.

 

Limitation of Use:
Not for the treatment of type 1 diabetes mellitus and/or diabetic ketoacidosis.

Dosage:

The recommended dose of TruGlif is 10 mg once daily in the morning, taken with or without food. In individuals tolerating TruGlif, the dose may be increased up to 25 mg or as directed by the physician.

Presentations:

  • TruGlif Tablets 10 mg & 25 mg are available in pack of 14’s